AERIE PHARMACEUTICALS INC - COM (AERI)

CUSIP: 00771V108

Q4 2014 13F Holders as of 31 Dec 2014

Type / Class
Equity / COM
Total 13F shares
21,463,770
Share change
+1,380,110
Total reported value
$626,614,711
Price per share
$29.19
Number of holders
98
Value change
+$50,471,026
Number of buys
57
Number of sells
36

Quarterly Holders Quick Answers

What is CUSIP 00771V108?
CUSIP 00771V108 identifies AERI - AERIE PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AERIE PHARMACEUTICALS INC - COM (AERI) as of Q4 2014

As of 31 Dec 2014, AERIE PHARMACEUTICALS INC - COM (AERI) was held by 98 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,463,770 shares. The largest 10 holders included Clarus Ventures, LLC, WELLINGTON MANAGEMENT GROUP LLP, JENNISON ASSOCIATES LLC, TPG Group Holdings (SBS) Advisors, Inc., DEERFIELD MANAGEMENT CO, JANUS CAPITAL MANAGEMENT LLC, BlackRock Fund Advisors, Novo A/S, SCHRODER INVESTMENT MANAGEMENT GROUP, and VANGUARD GROUP INC. This page lists 98 institutional shareholders reporting positions in this security for the Q4 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.